Brief: Quantum Genomics signs research collaborations
02/07/2015 07:03
July 2 (Reuters) - Quantum Genomics SA ALQGC.PA :
* Signs research collaboration agreement with University of
Ottawa Heart Institute and Center for Interdisciplinary Research
in Biology at College de Drance
* Announces goal to launch by mid-2016 a phase IIa human
clinical trial of its QGC101 drug candidate for the prevention
and treatment of heart failure
Source text for Eikon: ID:nACT40516
Further company coverage: ALQGC.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 6983920;))
Recent news on Quantum Genomics SA
See all newsBrief: Quantum Genomics Announces Resumption Of Discussions With HealthTech, Terminates Exclusive Negotiations With Vistacare Medical
Brief: Quantum Genomics Enters Into Exclusive Negotiations With Vistacare Medical
Brief: Quantum Genomics To Reduce Staff; Jean-Philippe Milon Becomes President and CEO
Brief: Quantum Genomics In Talks For New Strategic Project
Brief: Quantum Genomics Announces Lack Of Significant Efficacy For Firibastat In Their Phase Iii Study